Related Experiment Video

Updated: Jul 16, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer

Irene Esposito1, Hany Kayed, Shereen Keleg

  • 1Institute of Pathology, University of Heidelberg, Heidelberg, Germany.

Neoplasia (New York, N.Y.)
|February 28, 2007
PubMed

Insights

SPARC-like protein 1 (SPARCL1) shows varied expression in pancreatic tissues, with reduced levels in cancer cells but increased presence in tumor-associated vasculature. SPARCL1 inhibits invasion, suggesting a tumor-suppressor role.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • SPARC-like protein 1 (SPARCL1), a member of the SPARC family, is known to be downregulated in various tumors.
  • Understanding SPARCL1's role in pancreatic cancer is crucial for developing new therapeutic strategies.

Purpose of the Study:

  • To analyze the expression and localization of SPARCL1 in nontumorous and neoplastic pancreatic tissues.
  • To investigate the functional role of SPARCL1 in pancreatic cancer cell proliferation and invasion.

Main Methods:

  • Quantitative reverse transcription-polymerase chain reaction (qRT-PCR)
  • Laser capture microdissection (LCM)
  • Microarray analysis
  • Immunohistochemistry (IHC)
  • In vitro proliferation and invasion assays

Main Results:

  • Pancreatic ductal adenocarcinoma (PDAC) and other neoplasms showed increased SPARCL1 mRNA levels compared to normal pancreas.
  • SPARCL1 mRNA levels were low in microdissected and cultured pancreatic cancer cells.
  • SPARCL1 was detected in capillaries within inflammatory/tumor areas and islet cells, with higher vessel positivity in benign/borderline tumors and chronic pancreatitis than in PDAC.
  • Recombinant SPARCL1 inhibited pancreatic cancer cell invasion and moderately inhibited growth.

Conclusions:

  • SPARCL1 expression in pancreatic tissues correlates with vascularity.
  • SPARCL1 exhibits anti-invasive effects and reduced expression in metastasis, indicating a tumor-suppressor function.

More Related Videos

Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets03:37

Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets

Published on: March 1, 2024

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...